Ketamine produces a distinct set of short-lived effects on the brain and body, ranging from dissociation and altered perception to increased blood pressure and temporary memory impairment. When given intravenously, these effects begin within 10 to 30 seconds and typically last 5 to 15 minutes at anesthetic doses, though lower doses used for depression treatment produce milder effects that can linger for an hour or two. Here’s what actually happens during that window.
How Ketamine Works in the Brain
Ketamine’s primary target is a receptor involved in learning, memory, and perception called the NMDA receptor. It works by slipping into the receptor’s open channel and blocking it, which disrupts normal signaling between nerve cells. This receptor is found throughout the brain, but ketamine appears to hit certain inhibitory nerve cells (interneurons) with three to four times greater potency than other cells. When those inhibitory cells get shut down, excitatory neurons become disinhibited, firing more freely and flooding the brain with the neurotransmitter glutamate.
This surge of glutamate activity is what produces much of the acute experience. The dissociative, dreamlike quality of ketamine, sometimes described as feeling detached from your body or surroundings, is closely tied to this NMDA receptor blockade. Other drugs that block the same receptor, including PCP, produce strikingly similar dissociative and psychosis-like effects, which reinforces that this mechanism is central to what people feel during a ketamine experience.
Dissociation and Altered Perception
The most recognizable acute effect of ketamine is dissociation: a sense of detachment from your body, your surroundings, or both. People often describe feeling like they’re floating, watching themselves from outside, or moving through a dreamlike space. At higher doses, this can intensify into what’s colloquially called a “k-hole,” where awareness of the external world drops away almost entirely.
Alongside dissociation, ketamine commonly produces visual and auditory distortions, time perception changes, and a sense that objects or spaces look different than usual. Some people experience euphoria, while others find the altered state unsettling or confusing. These perceptual effects are dose-dependent. At the sub-anesthetic doses used for depression treatment (typically 0.5 mg/kg intravenously, though some patients respond to doses as low as 0.1 mg/kg), dissociation is usually mild to moderate and resolves within about two hours.
Effects on Memory and Thinking
Ketamine temporarily impairs several types of cognitive function while it’s active in the brain. Working memory, the ability to hold and manipulate information in your mind, takes a noticeable hit. So does episodic memory, which is your capacity to form and retrieve memories of specific events. Recognition memory and procedural learning, the kind involved in learning new sequences or tasks, are also affected during the acute phase.
These deficits are short-lived at clinical doses and generally resolve as the drug clears. But they explain why people often have hazy or fragmented recall of their experience during a ketamine infusion. Executive function, the mental processes involved in planning, decision-making, and impulse control, is similarly impaired while the drug is active.
Cardiovascular Changes
Unlike most sedatives and anesthetics, ketamine raises blood pressure and heart rate rather than lowering them. During sub-anesthetic infusions for depression, systolic blood pressure increases by an average of 16 mmHg and diastolic blood pressure by about 11 mmHg, with both peaking roughly 40 minutes after the infusion starts. Heart rate also climbs, though generally to a lesser degree.
For most healthy people, this temporary spike is clinically insignificant and resolves after the infusion ends. It’s one reason clinical settings monitor blood pressure during administration, and it’s also why people with uncontrolled high blood pressure or certain cardiovascular conditions may not be good candidates for ketamine treatment.
Breathing and Airway Reflexes
Ketamine stands apart from nearly every other sedative in how it affects breathing. Most drugs that induce unconsciousness, including propofol and benzodiazepines, suppress respiratory drive and relax the muscles that keep the airway open, creating a risk of airway collapse. Ketamine does the opposite. It actively stimulates breathing, increasing respiratory rate, airflow, and the proportion of each breath cycle spent inhaling. These values can run 1.5 to two times higher than during normal wakefulness.
Ketamine also strengthens the activity of the genioglossus, the tongue muscle that helps keep the upper airway open during sleep and sedation. This means that even at doses high enough to cause loss of consciousness, the airway tends to stay patent and ventilation is preserved. This respiratory profile is a major reason ketamine is favored for emergency sedation and procedural sedation in settings where advanced airway management isn’t readily available.
Nausea and Other Physical Effects
Nausea is one of the most common physical complaints during and shortly after ketamine administration, though actual vomiting is less frequent than many people expect. In a large analysis, vomiting occurred in about 7% of patients overall. The likelihood increases with higher doses. Other common physical effects include dizziness, blurred vision, and a general sense of heaviness or uncoordination in the limbs.
Increased salivation is another well-known effect, particularly at higher doses. Some people also report numbness or tingling sensations, which reflects ketamine’s analgesic (pain-blocking) properties. At sub-anesthetic doses, pain perception drops noticeably, which is why ketamine has a long history of use for acute pain management in emergency and surgical settings.
How Long the Effects Last
The timeline depends heavily on the dose and how it’s administered. Intravenous ketamine at anesthetic doses (around 2 mg/kg) produces dissociation within 10 to 30 seconds, with effects lasting roughly 5 to 15 minutes before consciousness begins to return. Intramuscular injection takes longer to kick in, usually 3 to 5 minutes, and effects last proportionally longer.
At the lower sub-anesthetic doses used for depression, the infusion itself typically runs 40 minutes. Dissociative symptoms peak during or just after the infusion and fade over the following one to two hours. Blood pressure changes follow a similar curve, peaking around 40 minutes and normalizing afterward. Cognitive effects, particularly the memory and concentration issues, generally clear within a few hours, though some people report feeling mentally foggy or fatigued for the rest of the day. Most clinical protocols ask patients not to drive or make important decisions for at least several hours after treatment.